{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:31:19Z","timestamp":1781195479282,"version":"3.54.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Central nervous system infections (CNSIs) are one of the most serious complications after neurosurgery, especially carbapenem-resistant bacterial meningitis. Owing to the poor blood-brain barrier permeability of most antibiotics, the treatment of CNSIs by intraventricular (IVT) administration is becoming a hot topic in clinical research. Currently, the treatment of CNSIs caused by carbapenem-resistant <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic> is mainly based on intraventricular injection of an antibiotic combined with one or more other systemic intravenous (IV) antibiotics, whereas there are few case reports of intraventricular injection of 2 antibiotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 57-year-old man with an open craniocerebral injury presented with dyspnea, high fever, and seizures associated with surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Intracranial infection caused by carbapenem-resistant <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic> was diagnosed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>On the advice of a clinical pharmacist, the patient was given tigecycline (100\u2009mg IV + 3\u2009mg IVT q12h) combined with amikacin (0.8\u2009g IV + 30\u2009mg IVT qd) antiinfective therapy. Ultimately, the pathogens in the cerebrospinal fluid were eradicated after 7 days, and the CNSIs were completely cured after 14 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient recovered and was discharged from the hospital without adverse reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>A series of in vitro and in vivo synergy tests of carbapenem-resistant <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic> showed that tigecycline combined with aminoglycosides had good synergistic effects and effectively suppressed bacterial resistance selection. Intravenous plus intraventricular tigecycline-amikacin seems to be a safe and effective treatment option for carbapenem-resistant <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic> CNSIs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029635","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:04:48Z","timestamp":1660169088000},"page":"e29635","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9106-416X","authenticated-orcid":false,"given":"Jiyao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Liaocheng People\u2019s Hospital, Liaocheng, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Liaocheng People\u2019s Hospital, Liaocheng, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Liaocheng People\u2019s Hospital, Liaocheng, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Liaocheng People\u2019s Hospital, Liaocheng, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Liaocheng People\u2019s Hospital, Liaocheng, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/IDR.S326456","article-title":"Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis.","volume":"15","author":"Karvouniaris","year":"2022","journal-title":"Infection and Drug Resistance"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods.","volume":"7","author":"Lee","year":"2016","journal-title":"Front Microbiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e7703","DOI":"10.1097\/MD.0000000000007703","article-title":"A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii.","volume":"96","author":"Fang","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ene.12789","article-title":"Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.","volume":"23","author":"De Bonis","year":"2016","journal-title":"Eur J Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/bcp.15238","article-title":"Intraventricular colistin sulphate as a last resort therapy in a patient with multidrug-resistant Acinetobacter baumannii induced post-neurosurgical ventriculitis.","volume":"88","author":"Yu","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijantimicag.2013.02.006","article-title":"Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrugresistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.","volume":"41","author":"Karaiskos","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e02881","DOI":"10.1128\/mBio.02881-20","article-title":"Colistin heteroresistance is largely undetected among carbapenem-resistant enterobacterales in the United States.","volume":"12","author":"Band","year":"2021","journal-title":"mBio"},{"key":"R9-20250504","first-page":"1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review.","volume":"5","author":"Yaghoubi","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/mdr.2021.0106","article-title":"Molecular characterization of carbapenem-resistant enterobacterales collected in the United States.","volume":"28","author":"Karlsson","year":"2022","journal-title":"Microb Drug Resist"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkl403","article-title":"Serum, tissue and body fluid concentrations of tigecycline after a single 100\u2009mg dose.","volume":"58","author":"Rodvold","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/bmc.3616","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method for the quantification of tigecycline in rat brain tissues.","volume":"30","author":"Munyeza","year":"2016","journal-title":"Biomed Chromatogr"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/IPC.0b013e318181fa38","article-title":"Tigecycline for the treatment of multidrug-resistant klebsiella pneumoniae meningitis.","volume":"17","author":"Dandache","year":"2009","journal-title":"Infectious Diseases in Clinical Practice"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/AAC.00635-10","article-title":"Low tigecycline concentrations in the cerebrospinal fluid of a neutropenic patient with inflamed meninges.","volume":"55","author":"Lengerke","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1345\/aph.1M480","article-title":"Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.","volume":"44","author":"Ray","year":"2010","journal-title":"Ann Pharmacother"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/00365548.2013.837957","article-title":"Cerebrospinal fluid penetration of tigecycline.","volume":"46","author":"Pallotto","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/bmc.3776","article-title":"Development and validation of an LC-MS\/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study.","volume":"30","author":"Mei","year":"2016","journal-title":"Biomed Chromatogr"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/1120009X.2017.1338846","article-title":"Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report.","volume":"30","author":"Wu","year":"2017","journal-title":"J Chemother"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"105592","DOI":"10.1016\/j.clineuro.2019.105592","article-title":"Multidrug-resistant Klebsiella oxytoca ventriculitis, successfully treated with intraventricular tigecycline: A case report.","volume":"188","author":"Soto-Hern\u00e1ndez","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e3126","DOI":"10.1097\/MD.0000000000003126","article-title":"Tigecycline treatment for carbapenem-resistant enterobacteriaceae infections, a systematic review and meta-analysis.","volume":"95","author":"Ni","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2146\/ajhp170632","article-title":"Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime\u2013avibactam and intrathecal amikacin.","volume":"75","author":"Gofman","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3171\/2018.9.PEDS18470","article-title":"Intraventricular tigecycline for the treatment of shunt infection: a case in pediatrics.","volume":"23","author":"Curebal","year":"2018","journal-title":"J Neurosurg Pediatr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e20160963","DOI":"10.1542\/peds.2016-0963","article-title":"Tigecycline therapy in an infant for ventriculoperitoneal shunt meningitis.","volume":"139","author":"Emiroglu","year":"2017","journal-title":"Pediatrics"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jcrc.2018.07.025","article-title":"Intraventricular CNS treatment with Colistin-Tigecycline combination: a case series.","volume":"47","author":"Tsolaki","year":"2018","journal-title":"J Crit Care"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1060028013510487","article-title":"Dual intraventricular plus systemic antibiotic therapy for the treatment of klebsiella pneumoniae carbapenemase-producing klebsiella pneumoniae ventriculitis.","volume":"48","author":"Nevrekar","year":"2014","journal-title":"Ann Pharmacother"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-022-04429-0","article-title":"A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.","volume":"41","author":"Demirlenk","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jmii.2016.03.003","article-title":"Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.","volume":"52","author":"Tang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/antibiotics10060736","article-title":"The synergistic activity and optimizing doses of tigecycline in combination with aminoglycosides against clinical carbapenem-resistant klebsiella pneumoniae isolates.","volume":"10","author":"Nulsopapon","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3389\/fmicb.2016.01304","article-title":"Tigecycline-amikacin combination effectively suppresses the selection of resistance in clinical isolates of KPC-producing klebsiella pneumoniae.","volume":"7","author":"Ni","year":"2016","journal-title":"Front Microbiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/jac\/dkab122","article-title":"In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.","volume":"76","author":"Ni","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fneur.2018.00518","article-title":"Multidrug resistant brain abscess due to acinetobacter baumannii ventriculitis cleared by intraventricular and intravenous tigecycline therapy: a case report and review of literature.","volume":"9","author":"Long","year":"2018","journal-title":"Front Neurol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12028-016-0269-3","article-title":"Systematic review of efficacy, pharmacokinetics, and administration of intraventricular aminoglycosides in adults.","volume":"25","author":"LeBras","year":"2016","journal-title":"Neurocrit Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:13:07Z","timestamp":1746331987000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":32,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029635","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}